Volume 129, Issue 3, Pages 863-873 (September 2005) Randomized, Placebo-Controlled, Esophageal Squamous Cell Cancer Chemoprevention Trial of Selenomethionine and Celecoxib Paul J. Limburg, Wenqiang Wei, Dennis J. Ahnen, Youlin Qiao, Ernest T. Hawk, Guoqing Wang, Carol A. Giffen, Guiqi Wang, Mark J. Roth, Ning Lu, Edward L. Korn, Yurong Ma, Kathleen L. Caldwell, Zheiwei Dong, Philip R. Taylor, Sanford M. Dawsey Gastroenterology Volume 129, Issue 3, Pages 863-873 (September 2005) DOI: 10.1053/j.gastro.2005.06.024 Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 1 Trial flow diagram. Gastroenterology 2005 129, 863-873DOI: (10.1053/j.gastro.2005.06.024) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 2 Change in severity of esophageal squamous dysplasia by intervention agent. □, Progression; , stable; , regression. (A) All subjects; (B) moderate dysplasia at baseline; (C) mild dysplasia at baseline. Gastroenterology 2005 129, 863-873DOI: (10.1053/j.gastro.2005.06.024) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 3 Change in severity of esophageal squamous dysplasia by intervention group. □, Progression; , stable; , regression. Gastroenterology 2005 129, 863-873DOI: (10.1053/j.gastro.2005.06.024) Copyright © 2005 American Gastroenterological Association Terms and Conditions